NEOSURF INJECTION 5 ML

How NEOSURF INJECTION 5 ML Works

• NEOSURF INJECTION 5 ML contains Beractant, a modified natural surfactant extracted from bovine lungs. This complex mixture of phospholipids, neutral lipids, fatty acids, and surfactant-associated proteins works by reducing surface tension at the air-liquid interface in the alveoli of the lungs. Premature infants, particularly those with Respiratory Distress Syndrome (RDS), often lack sufficient natural surfactant, leading to alveolar collapse and impaired gas exchange.
• When NEOSURF INJECTION 5 ML is administered intratracheally, it rapidly spreads across the alveolar surface, forming a monolayer that lowers surface tension. This reduction in surface tension stabilizes the alveoli, preventing them from collapsing during exhalation. By maintaining alveolar patency, NEOSURF INJECTION 5 ML improves lung compliance, reduces the work of breathing, and facilitates efficient gas exchange – allowing oxygen to enter the bloodstream and carbon dioxide to be expelled.
• Specifically, the phospholipid components, primarily dipalmitoylphosphatidylcholine (DPPC), are crucial for reducing surface tension. The surfactant-associated proteins, SP-B and SP-C, enhance the spreading and adsorption of the surfactant, further contributing to its efficacy. SP-A and SP-D, while present, play a lesser role in the acute effects but contribute to immune modulation and surfactant homeostasis in the longer term.
• In essence, NEOSURF INJECTION 5 ML acts as a replacement for the missing or deficient natural surfactant, restoring the normal biophysical properties of the lung and enabling proper respiratory function in premature infants with RDS. This significantly reduces the severity of RDS, improves survival rates, and minimizes the risk of long-term respiratory complications. Treatment with Neosurf improves oxygenation and reduces the need for ventilator support.

While NEOSURF INJECTION 5 ML is generally well-tolerated, some potential side effects may occur. These can include: * **Common Side Effects:** Temporary redness or swelling at the injection site, mild fever, irritability, feeding problems. * **Less Common Side Effects:** Apnea (temporary cessation of breathing), bradycardia (slow heart rate), hypotension (low blood pressure), increased risk of infection, intraventricular hemorrhage (bleeding in the brain), pulmonary air leak, pulmonary hemorrhage. * **Rare Side Effects:** Allergic reactions. **Important Note:** This is not an exhaustive list. Inform your doctor immediately if you observe any other unusual symptoms or reactions after the injection.

• Since NEOSURF INJECTION 5 ML is usually administered by a healthcare professional in a hospital setting, the possibility of missing a dose is unlikely. However, if you have concerns about a missed dose, please consult your doctor or the healthcare professional administering the medication.

• Keep NEOSURF INJ 5ML away from the reach of children and pets.
• Store NEOSURF INJ 5ML at room temperature.

• **Administer Under Medical Supervision:** NEOSURF INJECTION 5 ML should only be administered by trained healthcare professionals in a hospital or clinical setting where appropriate monitoring and resuscitative equipment are available. Premature infants requiring this medication often need careful observation.
• **Monitor Respiratory Function:** Closely monitor the infant's respiratory status during and after administration. Be alert for signs of respiratory distress, such as increased work of breathing, cyanosis, or apnea. Adjust ventilator settings as needed based on the infant's response.
• **Ensure Proper Dosage Calculation:** Accurate dosage calculation is crucial. The dosage of NEOSURF INJECTION 5 ML is determined based on the infant's birth weight. Double-check all calculations before administering the medication to avoid potential overdose or underdose.
• **Warm Before Administration:** Prior to administration, gently warm the vial of NEOSURF INJECTION 5 ML to room temperature. This helps ensure the medication is properly dispersed and reduces the risk of adverse effects. Follow the manufacturer's instructions for warming.
• **Administer Slowly and Carefully:** Administer NEOSURF INJECTION 5 ML slowly and carefully via an endotracheal tube directly into the infant's lungs. Distribute the dose evenly into both lungs by temporarily positioning the infant in different positions (e.g., right side down, left side down). This promotes optimal distribution of the surfactant.
• **Be Prepared for Potential Complications:** Be prepared to manage potential complications such as bradycardia (slow heart rate), hypotension (low blood pressure), or airway obstruction. Have emergency medications and equipment readily available.
• **Monitor Oxygen Saturation:** Continuously monitor the infant's oxygen saturation levels (SpO2) during and after surfactant administration. Aim for target SpO2 ranges as directed by the healthcare provider. Adjust oxygen delivery as needed.
• **Document Thoroughly:** Maintain accurate and detailed records of the administration process, including the time of administration, dosage, infant's response, and any adverse events observed. This information is essential for continuity of care.
• **Avoid Suctioning Immediately After:** Avoid suctioning the infant's airway immediately after surfactant administration, unless clinically necessary. Suctioning can remove the surfactant from the lungs and reduce its effectiveness. If suctioning is required, do it gently and sparingly.
• **Educate Parents:** Provide clear and concise information to the parents about the medication, its purpose, and potential benefits and risks. Address their concerns and answer their questions to help them feel more informed and involved in their baby's care.

• There is no specific information available regarding the interaction of Neosurf Injection 5 ml with food. It is generally administered by a healthcare professional and dietary adjustments are typically not required. However, always follow your doctor's advice regarding diet and other medications while receiving Neosurf.